Description

Darzalex 20mg/ml Injection (Daratumumab 400mg/20ml) – Darzalex Darzalex 20mg/ml Injection contains Daratumumab 400mg/20ml, a monoclonal antibody used in the treatment of multiple myeloma. It works by targeting the CD38 protein on myeloma cells, helping the immune system identify and destroy cancerous cells. Darzalex is trusted worldwide and marketed internationally under the brand name Darzalex. Key Uses Multiple Myeloma: As monotherapy for patients who have received prior therapies. In combination with other agents (lenalidomide, bortezomib, dexamethasone) for newly diagnosed and relapsed cases. Helps improve survival and disease control in patients with refractory or relapsed multiple myeloma. Dosage & Administration Administered as an intravenous infusion under medical supervision. Initial dose: 16 mg/kg body weight, frequency adjusted based on treatment phase. Infusion is given in cycles (weekly, biweekly, or monthly). Dose and schedule should be determined strictly by an oncologist/hematologist. Benefits Proven therapy for improving survival outcomes in multiple myeloma. Can be combined with standard chemotherapy regimens. Reduces tumor burden and helps maintain long-term remission. Backed by global clinical research and FDA/EMA approvals. FAQs Q1: What is Darzalex used for? It is prescribed for the treatment of multiple myeloma, either alone or in combination with other cancer medicines. Q2: How is Darzalex given? It is given as an IV infusion in a hospital/clinic under the supervision of an oncologist. Q3: What precautions should patients take? Pre-medications (steroids, antihistamines) are often prescribed to minimize infusion-related reactions. Regular monitoring is required. Storage Store in a refrigerator (2°C – 8°C). Do not freeze or shake. Keep away from direct light. SEO Keywords Darzalex injection price | Buy Daratumumab injection | Darzalex 20mg/ml suppliers | Darzalex cost in India | Daratumumab 400mg/20ml vial | Darzalex for multiple myeloma | Darzalex injection uses ✅ Conclusion: Darzalex 20mg/ml Injection (Daratumumab 400mg/20ml) is a globally recognized, effective treatment for multiple myeloma. By targeting cancer cells directly, it offers patients better outcomes and improved quality of life. Trusted under the brand name Darzalex, it is a vital option in advanced cancer care.